𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma

✍ Scribed by S. L. Wong; G. L. Kearns; J. P. Kemp; J. Drajesk; M. Chang; C. S. Locke; L. M. Dube; W. M. Awni

Publisher
Springer
Year
1998
Tongue
English
Weight
103 KB
Volume
54
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dose-proportional pharmacokinetics of a
Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers
✍ Shekman L. Wong; Jeffrey Drajesk; Min S. Chang; Galen Witt; Walid M. Awni πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 2 views

, a new potent 5-lipoxygenase inhibitor, is under development for the treatment of asthma. The pharmacokinetics and dose proportionality of ABT-761 after single doses (10 -160 mg) of ABT-761 in 24 healthy male volunteers were investigated in a double-blind, placebo-controlled study. The compound was

Population pharmacokinetics of zileution
Population pharmacokinetics of zileution, a selective 5-lipoxygenase inhibitor, in patients with rheumatoid arthritis
✍ W. M. Awni; G. R. Granneman; C. S. Locke; S. R. Brandwein; L. M. Dube πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 653 KB

The pharmacokinetics of zileuton, a novel selective 5-1ipoxygenase inhibitor, were studied in 37 patients with rheumatoid arthritis after administration of 200 mg, 400 rag, and 600 mg zileuton for 4 weeks. Patients had 6-h pharmacokinetic evaluation of zileuton on day 14. Plasma zileuton concentrati